Related Experiment Videos
The skeletal effects of primary hyperparathyroidism
1Section of Endocrinology, Yale University School of Medicine, New Haven, CT 06520, USA.
Bailliere'S Clinical Endocrinology and Metabolism
|April 1, 1997
Summary
Primary hyperparathyroidism (PHPT) accelerates bone loss, particularly in post-menopausal women. Early BMD measurement and treatment are crucial for managing bone density and preventing osteopenia in PHPT patients.
Area of Science:
- Endocrinology
- Bone Metabolism
- Mineral Disorders
Background:
- Primary hyperparathyroidism (PHPT) is a common endocrine disorder, frequently affecting post-menopausal women.
- It is characterized by hypercalcemia and chronic excess of parathyroid hormone.
- PHPT influences bone remodeling, stimulating both bone formation and resorption.
Purpose of the Study:
- To review the effects of PHPT on bone mineral density (BMD) and fracture incidence.
- To discuss interventional studies for managing bone loss in PHPT.
- To provide recommendations for patient management.
Main Methods:
- Review of studies on BMD and fracture incidence in PHPT.
- Analysis of interventional studies (parathyroid adenomectomy, estrogen replacement therapy).
- Synthesis of current evidence for clinical recommendations.
Main Results:
- PHPT is associated with accelerated bone loss, especially cortical bone, leading to osteopenia.
- Fracture incidence studies in PHPT have yielded conflicting results.
- Parathyroid adenomectomy and estrogen therapy have been shown to increase BMD in PHPT patients.
Conclusions:
- Patients with PHPT require BMD measurement to assess bone status.
- Treatment should aim to stabilize bone mass in cases of osteopenia or accelerated bone loss.
- Management strategies include surgical intervention and hormone replacement therapy.